Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate MIRA Pharmaceuticals, Inc. before investing.

In this article, we go over a few key elements for understanding MIRA Pharmaceuticals, Inc.’s stock price such as:

• MIRA Pharmaceuticals, Inc.’s current stock price and volume
• Why MIRA Pharmaceuticals, Inc.’s stock price changed recently
• Upgrades and downgrades for MIRA from analysts
• MIRA’s stock price momentum as measured by its relative strength

About MIRA Pharmaceuticals, Inc. (MIRA)

Before we jump into MIRA Pharmaceuticals, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.

Want to learn more about MIRA Pharmaceuticals, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about MIRA Pharmaceuticals, Inc..

MIRA Pharmaceuticals, Inc.’s Stock Price as of Market Close

As of April 21, 2026, 10:43 AM, CST, MIRA Pharmaceuticals, Inc.’s stock price was $1.100.

MIRA Pharmaceuticals, Inc. is down 1.79% from its previous closing price of $1.120.

During the last market session, MIRA Pharmaceuticals, Inc.’s stock traded between $1.100 and $1.140. Currently, there are approximately 40.82 million shares outstanding for MIRA Pharmaceuticals, Inc..

MIRA Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

MIRA Pharmaceuticals, Inc. Stock Price History

MIRA Pharmaceuticals, Inc.’s (MIRA) price is currently up 2.8% so far this month.

During the month of April, MIRA Pharmaceuticals, Inc.’s stock price has reached a high of $1.140 and a low of $0.990.

Over the last year, MIRA Pharmaceuticals, Inc. has hit prices as high as $2.450 and as low as $0.840. Year to date, MIRA Pharmaceuticals, Inc.’s stock is down 27.15%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused MIRA Pharmaceuticals, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 20, 2026, there were analysts who downgraded MIRA Pharmaceuticals, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate MIRA Pharmaceuticals, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on MIRA Pharmaceuticals, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about MIRA Pharmaceuticals, Inc. (MIRA) by visiting AAII Stock Evaluator.

Relative Price Strength of MIRA Pharmaceuticals, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 20, 2026, MIRA Pharmaceuticals, Inc. has a weighted four-quarter relative price strength of -4.71%, which translates to a Momentum Score of 37 and is considered to be Weak.

Want to learn more about how MIRA Pharmaceuticals, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

MIRA Pharmaceuticals, Inc. Stock Price: Bottom Line

As of April 21, 2026, MIRA Pharmaceuticals, Inc.’s stock price is $1.100, which is down 1.79% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like MIRA Pharmaceuticals, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.